In this Strategic Intent episode, In Vivo speaks with Ken Getz, executive director of the Tufts CSDD and research professor at the Tufts University School of Medicine, and Pamela Tanaerts, CMO and CSO at Medable, to discuss promising data from an AI Clinical Monitoring Agent.

Strategic Intent: Using Agentic AI To Create ‘The Self-Driving Clinical Trial, Kind Of Like The Car’

Citeline Podcasts

Hello and welcome to the Citeline Podcasts. I'm Annabelle Costa-Ferrera, reporter for Sightlines In Vivo, where we cover the business and strategy side of the pharmaceutical and biotech industry. Today I'm joined by Dr. Pamela Turnart, Chief Medical Officer at Medible, and Professor Ken Getz, Executive Director of the Tufts Centre for the Study of Drug Development and Research Professor at the Tufts University School of Medicine. Forming part of our Strategic Intent Podcast series, today's episode will broadly cover the use of artificial intelligence in the clinic, looking more specifically at the

analysis announcement last month, collaboratively from Medible and Tufts, which indicated that AI and clinical monitoring agents can deliver net financial gains as high as $21 million per drug development program and 82 times the return on investment. Medible is a health technology company that provides cloud-based digital platforms to streamline and accelerate clinical trials and drug development, including Agentic AI, which we'll go on to discuss later. And the Tufts Centre is known for the study of drug development and linked to Tufts University School of Medicine,

and is the only multidisciplinary academic research centre dedicated to optimising drug development, performance efficiency, quality and economics through a variety of robust empirical assessments. Pamela and Ken, welcome to both of you and thanks so much for joining me today. Thank you so much for the invitation. Likewise, it's a pleasure to be here and talk about this exciting work. Yeah, and so to start, maybe let's open with Pamela, if you could set the scene a bit for our listeners.

Strategic Intent: Using Agentic AI To Create ‘The Self-Driving Clinical Trial, Kind Of Like The Car’

Read the full transcript

The candid version is on a podcast,
not the earnings call.

Strategic Intent: Using Agentic AI To Create ‘The Self-Driving Clinical Trial, Kind Of Like The Car’

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.